Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?

Por Caimi, Paolo F., de Lima, Marcos
Publicado em 2014

Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndrome

Por Yao, David C., de Lima, Marcos
Publicado em 2014

Hematopoietic stem cell transplantation for Hodgkin's disease

Por Patah, Poliana, Fayad, Luis, de Lima, Marcos
Publicado em 2011

Cord Blood Transplantation: Can We Make it Better?

Por Metheny, Leland, Caimi, Paolo, de Lima, Marcos
Publicado em 2013

Emerging Therapies in Hematopoietic Stem Cell Transplantation

Por Reddy, Pavan, de Lima, Marcos, Koreth, John
Publicado no Biol Blood Marrow Transplant (2012)

Back to the future! The Evolving Role of Maintenance Therapy after Hematopoietic Stem Cell Transplantation

Por Hourigan, Christopher S., McCarthy, Philip, de Lima, Marcos
Publicado em 2013

Are 2 cords better than 1?

Por Shpall, Elizabeth, de Lima, Marcos, Jones, Roy, Champlin, Richard
Publicado em 2007

Advances in haploidentical stem cell transplantation

Por Bayraktar, Ulas Darda, de Lima, Marcos, Ciurea, Stefan Octavian
Publicado em 2011

Alternative donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia

Por Kanakry, Christopher G., de Lima, Marcos J., Luznik, Leo
Publicado no Semin Hematol (2015)

Timing Embryo Preservation for a Patient with High-Risk Newly Diagnosed Acute Myeloid Leukemia

Por Ye, Rebecca, Tomlinson, Benjamin, de Lima, Marcos, Malek, Ehsan
Publicado no Case Rep Hematol (2018)

Allograft for Myeloma: Examining Pieces of the Jigsaw Puzzle

Por Malek, Ehsan, El-Jurdi, Najla, Kröger, Nicolaus, de Lima, Marcos
Publicado no Front Oncol (2017)

Epigenetic therapy in allogeneic hematopoietic stem cell transplantation

Por Bashir, Qaiser, William, Basem Magdy, Garcia-Manero, Guillermo, de Lima, Marcos
Publicado em 2013

Overcoming the barriers to umbilical cord blood transplantation

Por KELLY, SUSAN STABA, PARMAR, SIMRIT, DE LIMA, MARCOS, ROBINSON, SIMON, SHPALL, ELIZABETH
Publicado no Cytotherapy (2010)

Allogeneic Stem Cell Transplantation for CML Resistant to Tyrosine Kinase Inhibitors

Por Champlin, Richard, Jabbour, Elias, Kebriaei, Partow, Anderlini, Paolo, Andersson, Borje, de Lima, Marcos
Publicado em 2011

The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era

Por Renault, Ilana Zalcberg, Scholl, Vanesa, Hassan, Rocio, Capelleti, Paola, de Lima, Marcos, Cortes, Jorge
Publicado em 2011

Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia

Por Andersson, Borje S., de Lima, Marcos, Thall, Peter F., Madden, Timothy, Russell, James A., Champlin, Richard E.
Publicado em 2009

Fludarabine-Melphalan Conditioning for AML and MDS: Alemtuzumab Reduces Acute and Chronic GVHD without Affecting Long-Term Outcomes

Por Van Besien, Koen, Kunavakkam, Rangesh, Rondon, Gaby, De Lima, Marcos, Artz, Andrew, Oran, Betul, Giralt, Sergio
Publicado no Biol Blood Marrow Transplant (2009)

Roentgenographic Evaluation of the Spine in Patients With Osteogenesis Imperfecta

Por de Lima, Marcos Vaz, de Lima, Fabiana Vaz, Akkari, Miguel, de Resende, Vanessa Ribeiro, Santili, Claudio
Publicado no Medicine (Baltimore) (2015)

Isolated skin relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplant

Por Ueda, Masumi, Silva, Carlos, Baer, Linda, Caimi, Paolo F., Cooper, Kevin, Honda, Kord, de Lima, Marcos
Publicado no Rev Bras Hematol Hemoter (2017)

Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantation

Por Mulanovich, Victor E, Jiang, Ying, de Lima, Marcos, Shpall, Elizabeth J, Champlin, Richard E, Ciurea, Stefan O
Publicado em 2011